Skip to content

Prospective Study Measuring Clinical Outcomes of Knee Arthroplasty Using the VERASENSE™ Knee System

Prospective Study Measuring Clinical Outcomes of Knee Arthroplasty Using the VERASENSE™ Knee System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01469299
Enrollment
285
Registered
2011-11-10
Start date
2011-10-31
Completion date
2016-12-31
Last updated
2017-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Post-traumatic Arthritis

Keywords

Ligament Balance, Total Knee Arthroplasty, Intra-operative Sensors

Brief summary

The primary objectives of this evaluation are: 1) To attempt to refine the current clinical understanding of balance 2) To determine if patients with quantifiably balanced knee joints exhibit improved clinical outcomes versus patient with residual imbalance, as measured by the VERASENSE™ Knee System Secondary objectives: * Determine whether a difference in inter-compartment loads and soft tissue tension exists between the physicians intra-operative feel compared to the quantifiable data measured by the VERASENSE™ Knee System * Determine which ligament releases are performed by the surgeon to improve soft tissue balance while utilizing the information from the VERASENSE™ Knee System * Evaluate range of motion, pain, physical function, activity level, and patient satisfaction between baseline (pre-operative) and post-operative follow-up as well as radiographic success and survivorship of the knee implants

Interventions

None listed

Sponsors

Orthosensor, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject must be a candidate for a primary total knee replacement * Subject must be diagnosed with one or more of the following conditions: osteoarthritis, avascular necrosis, rheumatoid or other inflammatory arthritis post-traumatic arthritis * Subject's joint must be anatomically and functionally suited to receive the selected implant * Subject is 50 years of age or older (≥ 50 yrs) at the time of consent * Subject is likely to be available for all study visits * Subject is able and willing to sign the informed consent and follow study procedures * Subject is not pregnant

Exclusion criteria

* Prior total knee arthroplasty * Subject has a mental condition that may interfere with the subject's ability to give an informed consent or willingness to fulfill the study requirements (i.e., severe mental retardation such that the Subject cannot understand the informed consent process, global dementia, prior strokes that interfere with the Subject's cognitive abilities, senile dementia, and Alzheimer's Disease) * Subject is pregnant * Subject has an active infection or joint sepsis * Subject has muscular, neurological or vascular deficiencies which compromise the affected extremity (i.e., Parkinson's Disease, Multiple Sclerosis, and Charcot joints) * Ligament insufficiencies, prior surgeries such as ACL or PCL reconstructions, posterolateral reconstructions, osteotomies, tibia plateau fractures * Range of Motion less than 90 degrees, flexion contracture of more than 20 degrees

Design outcomes

Primary

MeasureTime frame
Joint BalanceAt time of Total Knee Surgery

Secondary

MeasureTime frame
Patient Reported Outcome MeasuresChanges from Baseline at 3-years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026